Japan's CRISPR Fish Enters MarketJanuary 12, 2022
Two CRISPR-edited fishes were approved for sale in Japan. The country now has three approved CRISPR-edited foods to date.
The two fishes were developed by the Regional Fish Institute in collaboration with Kyoto University and Kindai University. The CRISPR-edited tiger puffer had its leptin receptor gene disrupted, resulting in the fish's increased appetite and rapid gain in weight. On the other hand, the CRISPR-edited sea bream had its myostatin protein disabled. This causes the fish to grow larger than the conventional sea bream using the same amount of feed. The traits are expected to reduce the farm production cost of the fishes.
Read the publication in Nature Biotechnology to learn more.
You might also like:
- Japan Begins Sale of Genome-Edited "Madai" Red Sea Bream
- Japan Starts Sale of Genome-Edited High-GABA Tomato
- Scientists Use TALENs to Edit Tuna
The Crop Biotech Update is a weekly newsletter of ISAAA, a non-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- International Team of Researchers Discover Plant Gene Crucial to Production of Clonal Seeds
- ARS Scientists Readying Wheat with Climate Resiliency
- Coexistence of GM Seed Production and Organic Farming A Success in Chile
- Smart Packaging from Corn Extends Food Shelf Life
- Biotech Crops Get Safety Approval After Pilot Testing in China
- Australian OGTR Receives Application for Field Trial of GM Sorghum
- Anti-stress Function of AtPDI1 Linked to Disulfide Isomerase Activity
- Transgene Inheritance Found to be Stable in Field Grown Pears
- Egyptian Scientists Develop Drought-Tolerant Tomatoes
Plant Breeding Innovations
- CRISPR to Supercharge Lettuce with Nutrients
- Japan's CRISPR Fish Enters Market
- VIB Conducts Three Field Trials of Genome-Edited Maize
Subscribe to CBU: